TCS 2314 (compound 3) is orally active and selective very late antigen-4 (VLA-4, α4β1 , CD49d/CD29) antagonist with an IC 50 of 4.4 nM.
Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Integrin
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.